newsfilter
← Latest News
GlobeNewswire·

Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults

§ 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB) protocol submission imminent New York, NY